April 22, 2018

Serotonin Reuptake Inhibitors May Improve Obstructive Sleep Apnea in Depression With and Without Epilepsy

A study of adults with both obstructive sleep apnea (OSA) and depression has demonstrated a link between the use of serotonin reuptake inhibitors (SRIs) and reduced severity of OSA in subjects with and without epilepsy. However, those with epilepsy displayed a more significant correlation between SRI use and reduced severity of OSA. This research was presented at the 70th annual American Academy of Neurology meeting, held April 21-27, 2018, in Los Angeles, California.

The results suggest that SRIs may serve as a potential treatment for OSA and depression, both in patients with and without epilepsy.

Related News

April 15, 2024

Transcriptomic Alterations in Cortical Astrocytes Following the Development of Post-Traumatic Epilepsy (PTE)

Featuring work of CURE Grantees Drs. Michelle Olsen and Michelle Theus. This work supports the ideas that astrocytes play a vital role in the progression of epileptogenesis following TBI.

April 15, 2024

Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients

“With such a clear response, we have advanced our planning of the focal epilepsy efficacy study for PRAX-628, expected to begin in the second half of 2024. We extend our thanks to the patients who participated in this PPR study,”

April 15, 2024

Study Reveals Key Mechanisms of a Rare Form of Epilepsy

This study reveals that the presence of KCNQ2 G256W variants affects both molecular and cellular aspects of KCNQ channel activity, including their ion-carrying capacity, expression, and placement within cells.